Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
42.38
+0.85 (2.05%)
Dec 24, 2025, 1:00 PM EST - Market closed
Terns Pharmaceuticals Market Cap
Terns Pharmaceuticals has a market cap or net worth of $4.51 billion as of December 24, 2025. Its market cap has increased by 706.28% in one year.
Market Cap
4.51B
Enterprise Value
4.21B
1-Year Change
706.28%
Ranking
Category
Stock Price
$42.38
Market Cap Chart
Since the IPO on February 5, 2021, Terns Pharmaceuticals's market cap has increased from $143.61M to $4.51B, an increase of 3,037.83%. That is a compound annual growth rate of 102.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 4.51B | 857.63% |
| Dec 31, 2024 | 470.56M | 17.33% |
| Dec 29, 2023 | 401.05M | -20.44% |
| Dec 30, 2022 | 504.08M | 182.17% |
| Dec 31, 2021 | 178.64M | 24.39% |
| Feb 5, 2021 | 143.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.20B |
| Johnson & Johnson | 496.77B |
| AbbVie | 405.69B |
| UnitedHealth Group | 294.69B |
| AstraZeneca | 284.34B |
| Novartis AG | 263.31B |
| Merck & Co. | 260.56B |
| Abbott Laboratories | 216.95B |